AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) Files An 8-K Submission of Matters to a Vote of Security Holders
Item 5.07 Submission of Matters to a Vote of Security Holders.
On February 13, 2020, AVEO Pharmaceuticals, Inc. (the Company) held a special meeting of stockholders (the Special Meeting). The Companys stockholders voted in the following manner with respect to the following proposal at the Special Meeting. No other matters were considered or voted upon at the Special Meeting.
1. An amendment to the Companys Restated Certificate of Incorporation to effect a reverse stock split of the Companys common stock, by a ratio of not less than 1-for-5 and not more than 1-for-15, and a proportionate reduction in the number of authorized shares of common stock, such ratio and the implementation and timing of the reverse stock split to be determined in the discretion of the Companys board of directors. This proposal was approved as follows:
Item 8.01 Other Events.
On February 13, 2020, the Companys Board of Directors approved a 1-for-10 reverse split of the Companys common stock that is expected to take effect on Wednesday, February 19, 2020 after the close of trading.